00:01
Phenylketonuria.
00:03
That is what we're going to
talk about in this presentation,
also known as PKU.
00:08
So what is PKU?
It is really based on phenylalanine,
which is a protein building block
that's needed by the body.
00:19
Now, this is an essential amino acid
that's needed for the synthesis
of proteins, catecholamines,
and melanins.
00:27
So it's responsible for a
lot of important things.
00:30
And by essential amino acid,
I mean that
you actually have to take this in
with your food.
00:38
Your body can't make
this on its own.
00:40
So you have to ingest
phenylalanine.
00:44
If our metabolism is normal,
we're going to ingest phenylalanine.
00:49
And that's going to go through
our systems,
our blood vessels
through our liver,
and then it's going to come
into contact
with phenylalanine hydroxylase.
00:58
This phenylalanine hydroxylase
is going to break up
that phenylalanine.
01:04
And it's going to then
interact with tyrosine
and continue on
through our metabolism.
01:10
Now, if you have an
abnormal metabolism,
then you don't have this
phenylalanine hydroxylase.
01:16
So we can't break this up,
and you get this phenylalanine
buildup into your system.
01:23
It can't interact
with the tyrosine.
01:25
And it can't continue on
through the metabolic journey.
01:29
That also results in the inability
of the body to make tyrosine.
01:36
So what happens with PKU?
You can either have a
complete enzyme deficiency,
which is the classic PKU,
or it can be a little less
than complete.
01:46
That's going to give
you degrees of symptoms.
01:49
They might be a little bit more
mild to moderate
than the classic PKU.
01:54
This is also an autosomal
recessive condition.
01:58
So if you remember from
previous presentation,
that means
that you have to have
the recessive gene
from both parents.
02:08
So what are some signs
and symptoms of PKU?
They largely have to do
with brain development.
02:14
So you might see an infant
that has microcephaly,
because if your brain
is not developing,
then the head is not going to be
as big as you would expect.
02:24
You're going to have some possibly
irreversible
intellectual disability,
some behavioral abnormalities.
02:31
So these infants and children
have frequent temper tantrums,
and sometimes even
engage in self-harm.
02:39
They might have
seizures, skin diseases.
02:42
One of the hallmarks of PKU is that
these children often have eczema,
and much fairer skin, hair, and eyes
than their siblings.
02:51
Remember that melanin production
is part of what phenylalanine
does for the body.
02:57
So if it is not able to transition
into the metabolism,
then you're going to have some
of these skin findings.
03:06
There's also going to be a
musty smell to the breath,
the skin, and the urine.
03:11
something that just
doesn't smell quite right.
03:15
So how do we figure out if this is
what's going on with our patient?
There is widespread neonatal
screening for PKU in many countries.
03:24
And this is one of the things that
the US does routinely.
03:29
If not detected via
neonatal screening, though,
the infant is really going to start
exhibiting symptoms
as soon as we feed them,
because remember,
breast milk and formula
both have a lot of protein.
03:45
So, if we suspect PKU, because
the infant starts to have symptoms,
especially right after
they're being fed,
then we can send
a serum amino acid profile.
03:57
In that profile, we should find
an elevated concentration
of the phenylalanine.
04:02
And remember, this is because
the body can't break it down.
04:07
We can also do
molecular genetic testing
if we want to get
a little bit more in depth.
04:13
Now, if we discover
that our patient has PKU,
what can we do for them?
Really,
we have to ingest phenylalanine
and we get most of that through
protein containing foods.
04:28
So anything that has high levels
of protein - beef, eggs, chicken,
those types of things are
going to be a little problematic
for patients with PKU.
04:38
We also get some
phenylalanine from
vegetables,
fruits, and whole grains.
04:46
There's also phenylalanine
that is present in breast milk.
04:51
So, what does that
mean for our patients?
We're really going to have to
have them on a strict diet.
04:57
And there are some medications
that we can do
to help them break that
phenylalanine down.
05:03
One of them is sapropterin
and the other one is
phenylalanine ammonia lyase.
05:09
So, the term "lyase", when you see
A-S-E on the end of any medication,
that means that it is formulated
to help break something down.
05:23
Patients with PKU are going
to need a lot of monitoring,
and this is going to require
a multidisciplinary team.
05:31
Infants that have PKU are we're
really going to be checking those
phenylalanine levels, weekly.
05:37
We want to make sure that
they are in a good place,
and that we've keep
those levels low,
especially because
once neurologic changes,
happen,
then they become irreversible.
05:48
So we want to keep them
from happening.
05:51
Once these children
get a little bit older,
we may not need to monitor them
quite as frequently
because their diet becomes
a little bit more stable.
06:00
And then when they're
older than 12 years,
then we will be checking
these levels monthly.
06:06
So what are the outcomes
for patients with PKU?
With really good dietary treatment,
we can reverse all the signs of PKU
except for cognitive impairment
that's already occurred.
06:20
So if we already have learning
problems, or cognitive issues,
and we have not yet gotten
the PKU under control,
we're not going to be able
to reverse those
but we can reverse other symptoms.
06:33
We want to make sure that we have
really good dietary restrictions,
because that's
what's going to give us
these good cognitive outcomes.
06:42
When we have
good dietary restriction,
and we should be working with
a metabolic dietitian,
then these children can have
IQ scores
that are in the normal range.
06:53
So let's go through
the clinical judgment model
and think about PKU
from this perspective.
07:01
So one of the first things we do
in the clinical judgment model
is we try to recognize the cues
in our patient.
07:07
If we have an infant that presents
with these symptoms
like microcephaly, or
seizures, or skin diseases,
especially if these symptoms come
on immediately after being fed,
then we're going to suspect PKU.
07:24
So, how do we analyze
what we're seeing in our patient?
Many infants will be diagnosed
with newborn screening.
07:32
But if this doesn't happen,
then these symptoms are really
going to start after a diet
that contains phenylalanine,
which is most commercial formulas.
07:41
So anything
that's protein containing
is going to cause these patients
to have symptoms.
07:45
So that's a big cue that you
might be dealing with PKU.
07:48
They're being fed and
they develop symptoms.
07:52
So what are we going
to do about that?
There are a couple of different
things that we can do.
07:57
But the mainstay of treatment
is really going to view these
dietary restrictions.
08:02
Which as children
are growing older,
and especially getting
into the teenage years,
it's really important to work
with that metabolic dietician,
because this diet in particular
with the low protein
can be really hard to stick to.
08:15
So you're going to need those
dietary changes,
and then there is some pharmacologic
treatment that we can offer.
08:22
So as you're going through
the clinical judgment model,
just remember, that you're
going to want to go through
each one of these steps,
and we've highlighted a few
to help you think through this.